Business Context and Reporting Period
Company: Henry Schein, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: July 1, 2006
Business Overview: Henry Schein is a leading distributor of healthcare products and services to office-based practitioners (dental, medical, animal health) in North America and Europe. Operations are divided into two segments: Healthcare Distribution and Technology.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended July 1, 2006 |
Six Months Ended July 1, 2006 |
|---|---|---|
| Net Sales | $1,220,360 | $2,382,141 |
| Gross Profit | $359,460 | $697,062 |
| Gross Margin | 29.5% | 29.3% |
| Operating Income | $76,748 | $137,666 |
| Net Income (Continuing Ops) | $45,218 | $80,845 |
| Diluted EPS (Continuing Ops) | $0.50 | $0.90 |
| Cash & Equivalents | $138,334 | $138,334 |
| Total Debt | $519,458 | $519,458 |
| Working Capital | $850,656 | $850,656 |
Note: Net cash provided by operating activities for the six months ended July 1, 2006, was $617 thousand, a significant decrease from $67.2 million in the prior year period, primarily due to timing changes in working capital.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 10.5% ($115.9 million) for the quarter and 9.9% ($214.7 million) for the six months compared to the prior year. Growth was driven by internal volume increases and acquisitions, partially offset by foreign currency exchange impacts.
- Segment Performance:
- Dental: Sales up 10.8% (quarter) and 10.6% (six months), driven by consumable and equipment growth.
- Medical: Sales up 14.3% (quarter) and 10.5% (six months), driven by volume and acquisitions.
- International: Sales up 6.9% (quarter) and 8.6% (six months), with strong local currency growth offset by currency translation declines.
- Technology: Sales up 3.7% (quarter) and 6.0% (six months), driven by electronic and financial services.
- Profitability: Gross margins improved across segments (Healthcare Distribution: 28.5% vs 28.1%; Technology: 77.1% vs 75.9% for the quarter). Operating income increased 14.5% for the quarter and 14.4% for the six months.
- Discontinued Operations: The company sold its Hospital Supply Business in April 2006 for $36.5 million, resulting in a $32.3 million pre-tax loss on the sale. This is classified as a discontinued operation.
- Accounting Change: The company adopted FAS 123(R) effective January 1, 2006, using the modified retrospective application method, which impacted prior period EPS comparisons.
Guidance, Outlook, and Risks
- Capital Allocation: The company expects to invest approximately $35.0 million in capital projects for the remainder of the fiscal year to modernize facilities and integrate acquisitions.
- Acquisitions: Completed acquisitions of NLS Animal Health ($110M revenue) and Island Dental ($84M revenue) in the first half of 2006. The company continues to seek acquisition opportunities to expand its role in the healthcare industry.
- Stock Repurchases: As of July 1, 2006, the company had repurchased $112.0 million of common stock under its program, with $88.0 million remaining available.
- Liquidity: Management believes cash, securities, and a $300 million revolving credit facility (with $100 million expansion feature) provide sufficient liquidity. No borrowings were outstanding under the revolving facility as of July 1, 2006.
- Risks: Key risks include industry consolidation, changes in healthcare regulations, dependence on third-party manufacturers, foreign currency fluctuations, and potential increases in shipping costs. The company also faces product liability claims, though management believes these are covered by insurance or indemnification.
- Contingencies: The company has contingent payment obligations of up to $13.0 million related to the sale of the Hospital Supply Business, dependent on buyer collections and sales performance.
Investor Verification Checklist
- Working Capital Volatility: Verify the reasons for the sharp decline in operating cash flow ($67.2M to $0.6M) and the impact of inventory build-up and accounts payable timing.
- Discontinued Operations: Confirm the final accounting treatment and any remaining contingent liabilities related to the $32.3 million loss on the Hospital Supply Business sale.
- Acquisition Integration: Assess the integration progress and synergies realized from the NLS Animal Health and Island Dental acquisitions.
- Foreign Currency Impact: Monitor the effect of currency exchange rates on the International segment, which saw a 5.2% decline in sales due to FX in the six-month period.
- Convertible Debt: Review the terms of the $240 million convertible notes (due 2034) and the conditions under which they may be converted or redeemed.